title: Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections.
abstract: Retrocyclins are humanized versions of the -defensin peptides expressed by the leukocytes of several nonhuman primates. Previous studies, performed in serum-free media, determined that retrocyclins 1 (RC1) and RC2 could prevent successful germination of Bacillus anthracis spores, kill vegetative B. anthracis cells, and inactivate anthrax lethal factor. We now report that retrocyclins are extensively bound by components of native mouse, human, and fetal calf sera, that heat-inactivated sera show greatly enhanced retrocyclin binding, and that native and (especially) heat-inactivated sera greatly reduce the direct activities of retrocyclins against spores and vegetative cells of B. anthracis. Nevertheless, we also found that retrocyclins protected mice challenged in vivo by subcutaneous, intraperitoneal, or intranasal instillation of B. anthracis spores. Retrocyclin 1 bound extensively to B. anthracis spores and enhanced their phagocytosis and killing by murine RAW264.7 cells. Based on the assumption that spore-bound RC1 enters phagosomes by "piggyback phagocytosis," model calculations showed that the intraphagosomal concentration of RC1 would greatly exceed its extracellular concentration. Murine alveolar macrophages took up fluorescently labeled retrocyclin, suggesting that macrophages may also acquire extracellular RC1 directly. Overall, these data demonstrate that retrocyclins are effective in vivo against experimental murine anthrax infections and suggest that enhanced macrophage function contributes to this property.
authors.affiliation: Bacteriology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA. susan.welkos@amedd.army.mil
authors.forename: S
authors.initials: S
authors.lastname: Welkos
authors.forename: C K
authors.initials: CK
authors.lastname: Cote
authors.forename: U
authors.initials: U
authors.lastname: Hahn
authors.forename: O
authors.initials: O
authors.lastname: Shastak
authors.forename: J
authors.initials: J
authors.lastname: Jedermann
authors.forename: J
authors.initials: J
authors.lastname: Bozue
authors.forename: G
authors.initials: G
authors.lastname: Jung
authors.forename: P
authors.initials: P
authors.lastname: Ruchala
authors.forename: P
authors.initials: P
authors.lastname: Pratikhya
authors.forename: T
authors.initials: T
authors.lastname: Tang
authors.forename: R I
authors.initials: RI
authors.lastname: Lehrer
authors.forename: W
authors.initials: W
authors.lastname: Beyer
mesh_terms: D000818:Animals; D000881:Anthrax / Q000276:immunology / Q000517:prevention & control*; D001408:Bacillus anthracis / Q000187:drug effects / Q000472:pathogenicity*; D002460:Cell Line; D023082:Defensins / Q000627:therapeutic use*; D005260:Female; D008264:Macrophages / Q000187:drug effects*; D051379:Mice; D008807:Mice, Inbred BALB C; D010587:Phagocytosis / Q000187:drug effects
chemical_list: D023082:Defensins; C450142:theta-defensin